Status:
RECRUITING
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
Lead Sponsor:
Umeå University
Collaborating Sponsors:
University Hospital, Linkoeping
Lund University Hospital
Conditions:
Pancreas Cancer
Pancreas Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancer
Detailed Description
This is a multicenter pragmatic prospective observational study including Nordic hospitals treating patients with borderline resectable and locally advanced pancreatic cancer. Eligibility will be asse...
Eligibility Criteria
Inclusion
- Confirmed or suspected invasive pancreatic primary tumor
- Tumor classified as borderline resectable or locally advanced disease according to NCCN guidelines
Exclusion
- Suspected endocrine tumor
- Suspected non-pancreatic periampullary tumor
- Distant metastasis
- Age \< 18 years
- Patient unable to understand verbal or written information interfering with informed consent or treatment
- Mental or organic disorder interfering with informed consent or treatments
Key Trial Info
Start Date :
April 19 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05356039
Start Date
April 19 2022
End Date
May 1 2028
Last Update
November 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Surgical Clinic at Umeå University Hospital
Umeå, Sweden, 90185